Lonza Group Ltd (LZAGY)
56.23
+0.68
(+1.22%)
USD |
OTCM |
May 24, 16:00
Lonza Group Cash and Short Term Investments (Quarterly): 1.986B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.986B |
| June 30, 2023 | 2.389B |
| June 30, 2023 | 2.389B |
| December 31, 2022 | 2.399B |
| June 30, 2022 | 2.551B |
| June 30, 2022 | 2.551B |
| December 31, 2021 | 3.483B |
| June 30, 2021 | 543.98M |
| June 30, 2021 | 543.98M |
| December 31, 2020 | 566.57M |
| June 30, 2020 | 585.63M |
| June 30, 2020 | 585.63M |
| December 31, 2019 | 521.20M |
| June 30, 2019 | 422.79M |
| June 30, 2019 | 422.79M |
| December 31, 2018 | 468.24M |
| June 30, 2018 | 489.12M |
| June 30, 2018 | 489.12M |
| December 31, 2017 | 491.74M |
| June 30, 2017 | 3.335B |
| June 30, 2017 | 3.335B |
| December 31, 2016 | 269.27M |
| Date | Value |
|---|---|
| June 30, 2016 | 262.32M |
| June 30, 2016 | 262.32M |
| December 31, 2015 | 280.24M |
| June 30, 2015 | 241.83M |
| June 30, 2015 | 241.83M |
| December 31, 2014 | 211.36M |
| June 30, 2014 | 308.55M |
| June 30, 2014 | 308.55M |
| December 31, 2013 | 344.80M |
| June 30, 2013 | 290.95M |
| June 30, 2013 | 290.95M |
| December 31, 2012 | 469.93M |
| June 30, 2012 | 287.98M |
| June 30, 2012 | 287.98M |
| December 31, 2011 | 208.39M |
| June 30, 2011 | 117.60M |
| December 31, 2010 | 265.31M |
| June 30, 2010 | 109.46M |
| December 31, 2009 | 135.19M |
| June 30, 2009 | 216.37M |
| December 31, 2008 | 531.49M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
422.79M
Minimum
Jun 2019
3.483B
Maximum
Dec 2021
1.463B
Average
585.63M
Median
Jun 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Roche Holding AG | 12.51B |
| AC Immune SA | 116.17M |
| CRISPR Therapeutics AG | 2.108B |
| Addex Therapeutics Ltd | 4.603M |
| NLS Pharmaceutics Ltd | 0.8977M |